IRCT20200425047202N1已完成3 期
The saftey and efficacy of intradermal injection of type A butulinum toxin in chemotherapy induced peripheral neuropathy
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 69 years（—）
- 性别
- All
入选标准
- •Chemotherapy induced neuropathy in patients treated with taxans or platinums with grade 2 or more of neuropathy
排除标准
- •Lack of cooperation///////
- •History of neuropathy before chemotherapy
- •History of allergy to the butulinum toxin
- •Local infection of the injection places
- •Rradiculopathy
- •History of mental disease
- •Alcolol or substance abuse
- •Known renal disease
- •History of miastenia gravis
- •Use of aminoglycosides
研究者
相似试验
招募中
2 期
The efficacy and safety of subcutaneous injection of bortezomib combined with doxorubicin and dexamethasone for untreated multiple myeloma patients.multiple myelomaJPRN-UMIN000007803ational Hospital Organization Disaster Medical Center35
已完成
2 期
Immunogenicity and safety of intradermal injection of reduced dose Inactivated Poliovirus vaccine (IPV) with a jet injector in healthy adultsinfantile paralysispolio10047438NL-OMON32437ederlands Vaccin Instituut120
进行中（未招募）
不适用
Immunogenicity and safety of intradermal injection of reduced dose Inactivated Poliovirus vaccine (IPV) with a jet injector in healthy adults - Intradermal injection of reduced dose IPV in adultsEUCTR2009-015175-27-NLetherlands Vaccine Institute
尚未招募
1 期
Assessment of the effect of exosomes in the treatment of melasmaIRCT20221130056672N6Tehran University of Medical Sciences30
尚未招募
1 期
Investigating nanofat injection and conditioned medium derived from stem cells in the treatment of androgenic alopeciaHair loss.Nonscarring hair loss, unspecifiedL65.9IRCT20200127046282N34Tehran University of Medical Sciences10